, also known as UBI, UVBI, (for ultraviolet blood irradiation) is thought of as a new treatment. However, it was first developed in the 1930s as a treatment for the polio virus.and other viral and bacterial infections. With the advent of vaccines and antibiotics it fell into disuse and was almost forgotten. With the dangers and lack of efficacy of vaccination now increasingly appreciated, the development of dangerous antibiotic resistant species of bacteria, and with the difficulty eradicating many viruses, including those involved in AIDS, photoluminescence has once again come to be thought of as a viable alternative therapy. Over 65 years of research and clinical data now exist to vouch for the safety of this treatment and it is making a resurgence in the hands of a small but growing number of practitioners.
The procedure is disarmingly simple, safe, and effective against a broad spectrum of viruses and bacteria. Only 5% of the patients blood is treated over a 20 minute period using the accepted therapeutic UV band of light waves. The effect on the blood which is treated spreads throughout the body and clinical improvement is ordinarily rapid. The device itself is safe, non-toxic, easy to apply, and uses no drugs. Photoluminescence is a viable and effective treatment option for many diverse medical conditions.
Ultraviolet blood irradiation produces a rapid detoxifying effect with waning of toxic symptoms. The concentration of venous oxygen is increased in those with depressed blood oxygen values. There is a rapid increase in resistance to both acute and chronic viral and bacterial infection and no harmful effects have been observed. Diseases which have been successfully treated include viral infections, hepatitis, bacterial infections, hypoxemia, and many others in the category of blood-bourne infections. Three to five treatments usually inactivate most viruses. There is no risk, hazard or pain to the patient. Costs for this treatment are low. Photoluminescent therapy is available now for use by licensed health practitioners. Studies are now underway to evaluate the usefulness of photoluminescent therapy in the treatment of Alzheimer's disease, malaria, cancer, and chronic fatigue syndrome.